RDS is committed to supporting the identification of the causes of the intellectual impairments associated with Down syndrome and to facilitating the development of pharmacological therapies to improve memory, learning and communication in persons with Down syndrome. Remarkable progress has already been made over a very short time. In fact, a human clinical trial has already begun, less than a decade after the support of private foundations stimulated the progress of Down syndrome cognitive research. Your support will help translate these research initiatives into a reality.
Please join with the RDS Runners as their miles help RDS fund research that already has made extraordinary progress.